Related Experiment Video
Updated: Feb 12, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
[Side effects of biologic therapies in psoriasis]
A Altenburg1,2, M Augustin3, C C Zouboulis4
1Hochschulklinik für Dermatologie, Venerologie und Allergologie, Immunologisches Zentrum, Städtisches Klinikum Dessau, Medizinische Hochschule Brandenburg Theodor Fontane, Auenweg 38, 06847, Dessau-Roßlau, Deutschland. andreas.altenburg@klinikum-dessau.de.
Background:
The introduction of biologics has revolutionized the treatment of moderate to severe plaque psoriasis. Due to the continuous expansion of biological therapies for psoriasis, it is particularly important to acknowledge efficacy and safety of the compounds not only in clinical trials but also in long-term registry-based observational studies.
Aim:
Typical side effects and significant risks of antipsoriatic biologic therapies considering psoriatic control groups are presented.
Materials And Methods:
A selective literature search was conducted in PubMed and long-term safety studies of the psoriasis registries PsoBest, PSOLAR and BADBIR were evaluated.
Results And Discussion:
To assess the long-term safety of biologics, the evaluation of the course of large patient cohorts in long-term registries is of particular medical importance. Newer biologic drugs seem to exhibit a better safety profile than older ones.
Related Concept Videos
Biological Effects of Radiation
Gene Therapy
What is Conservation Biology?
Group Therapy
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...

